Trial intelligence / Profile preview

Suramin and Fluorouracil in Metastatic Renal Cell Carcinoma

NCT00083109Phase 2Completed

Sponsor
National Cancer Institute
Start
Mar 2004
Primary completion
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of suramin in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Mar 2004; status: completed.

02

Drugs

suramin
03

Conditions

renal cell carcinoma (RCC)

Beyond the preview

Go deeper on NCT00083109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00083109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call